ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer
Int J Gynecol Cancer
.
2012 Jan;22(1):175.
doi: 10.1097/IGC.0b013e3182261f15.
Authors
Ate G J van der Zee
,
Nicoletta Colombo
,
Gerald Gitsch
,
Nicolas Reed
,
Frederic Amant
,
David Cibula
,
Vesna I Kesic
,
Rainer Kimmig
,
Alberto D B Lopes
,
Janina Markowska
,
Christian Marth
,
Alexander Radolakis
,
Helga Salvesen
,
Daiva Vaitkiene
,
René H M Verheijen
,
Paolo Zola
PMID:
22193647
DOI:
10.1097/IGC.0b013e3182261f15
No abstract available
Publication types
Editorial
Comment
MeSH terms
CA-125 Antigen / metabolism*
Carcinoma, Ovarian Epithelial
Female
Humans
Neoplasm Recurrence, Local / diagnosis*
Neoplasms, Glandular and Epithelial / metabolism*
Ovarian Neoplasms / metabolism*
Substances
CA-125 Antigen